Click for best price
Hip Tendinitis Market Size, Share 2024
| Market size in 2023 |
US$ 296.9 million
|
Forecast Market size by 2030 |
US$ 412.3 million
|
| Growth Rate |
CAGR of 4.8% |
Number of Pages |
66 Pages |
The global Hip Tendinitis market was valued at US$ 296.9 million in 2023 and is projected to reach US$ 412.3 million by 2030, at a CAGR of 4.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Internal Snapping Hip Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Hip Tendinitis include Almatica Pharma, AstraZeneca, Bayer, Boehringer Ingelheim Pharmaceuticals, Merck & Co., Pfizer, Abbott, GlaxoSmithKline and Teva Pharmaceuticals, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Hip tendinitis is an uncomfortable inflammatory condition when a tendon in the hip becomes iritated or inflamed. Other names for it include hip tendonitis and hip flexor tendonitis. The rapidly increasing rate of the senior population worldwide and growing sports activities are primarily increasing the demand for hip tendonitis treatment.
This report aims to provide a comprehensive presentation of the global market for Hip Tendinitis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hip Tendinitis. This report contains market size and forecasts of Hip Tendinitis in global, including the following market information:
- Global Hip Tendinitis Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global top five companies in 2023 (%)
We surveyed the Hip Tendinitis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hip Tendinitis Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Hip Tendinitis Market Segment Percentages, by Type, 2023 (%)
- Internal Snapping Hip
- External Snapping Hip
- Intra-articular Snapping Hip
Global Hip Tendinitis Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Hip Tendinitis Market Segment Percentages, by Application, 2023 (%)
- Hospitals & Clinics
- Medical Research Centers
- Academic Institutes
- Others
Global Hip Tendinitis Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Hip Tendinitis Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Hip Tendinitis revenues in global market, 2019-2024 (estimated), ($ millions)
- Key companies Hip Tendinitis revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Almatica Pharma
- AstraZeneca
- Bayer
- Boehringer Ingelheim Pharmaceuticals
- Merck & Co.
- Pfizer
- Abbott
- GlaxoSmithKline
- Teva Pharmaceuticals
- Lupin Pharmaceuticals
- Geri-Care Pharmaceuticals
- Perrigo Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hip Tendinitis, market overview.
Chapter 2: Global Hip Tendinitis market size in revenue.
Chapter 3: Detailed analysis of Hip Tendinitis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hip Tendinitis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Hip Tendinitis Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 296.9 million
|
| Forecast Market size by 2030 |
US$ 412.3 million
|
| Growth Rate |
CAGR of 4.8% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hip Tendinitis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hip Tendinitis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hip Tendinitis Overall Market Size
2.1 Global Hip Tendinitis Market Size: 2023 VS 2030
2.2 Global Hip Tendinitis Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hip Tendinitis Players in Global Market
3.2 Top Global Hip Tendinitis Companies Ranked by Revenue
3.3 Global Hip Tendinitis Revenue by Companies
3.4 Top 3 and Top 5 Hip Tendinitis Companies in Global Market, by Revenue in 2023
3.5 Global Companies Hip Tendinitis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hip Tendinitis Players in Global Market
3.6.1 List of Global Tier 1 Hip Tendinitis Companies
3.6.2 List of Global Tier 2 and Tier 3 Hip Tendinitis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hip Tendinitis Market Size Markets, 2023 & 2030
4.1.2 Internal Snapping Hip
4.1.3 External Snapping Hip
4.1.4 Intra-articular Snapping Hip
4.2 By Type - Global Hip Tendinitis Revenue & Forecasts
4.2.1 By Type - Global Hip Tendinitis Revenue, 2019-2024
4.2.2 By Type - Global Hip Tendinitis Revenue, 2025-2030
4.2.3 By Type - Global Hip Tendinitis Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hip Tendinitis Market Size, 2023 & 2030
5.1.2 Hospitals & Clinics
5.1.3 Medical Research Centers
5.1.4 Academic Institutes
5.1.5 Others
5.2 By Application - Global Hip Tendinitis Revenue & Forecasts
5.2.1 By Application - Global Hip Tendinitis Revenue, 2019-2024
5.2.2 By Application - Global Hip Tendinitis Revenue, 2025-2030
5.2.3 By Application - Global Hip Tendinitis Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Hip Tendinitis Market Size, 2023 & 2030
6.2 By Region - Global Hip Tendinitis Revenue & Forecasts
6.2.1 By Region - Global Hip Tendinitis Revenue, 2019-2024
6.2.2 By Region - Global Hip Tendinitis Revenue, 2025-2030
6.2.3 By Region - Global Hip Tendinitis Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Hip Tendinitis Revenue, 2019-2030
6.3.2 US Hip Tendinitis Market Size, 2019-2030
6.3.3 Canada Hip Tendinitis Market Size, 2019-2030
6.3.4 Mexico Hip Tendinitis Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Hip Tendinitis Revenue, 2019-2030
6.4.2 Germany Hip Tendinitis Market Size, 2019-2030
6.4.3 France Hip Tendinitis Market Size, 2019-2030
6.4.4 U.K. Hip Tendinitis Market Size, 2019-2030
6.4.5 Italy Hip Tendinitis Market Size, 2019-2030
6.4.6 Russia Hip Tendinitis Market Size, 2019-2030
6.4.7 Nordic Countries Hip Tendinitis Market Size, 2019-2030
6.4.8 Benelux Hip Tendinitis Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Hip Tendinitis Revenue, 2019-2030
6.5.2 China Hip Tendinitis Market Size, 2019-2030
6.5.3 Japan Hip Tendinitis Market Size, 2019-2030
6.5.4 South Korea Hip Tendinitis Market Size, 2019-2030
6.5.5 Southeast Asia Hip Tendinitis Market Size, 2019-2030
6.5.6 India Hip Tendinitis Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Hip Tendinitis Revenue, 2019-2030
6.6.2 Brazil Hip Tendinitis Market Size, 2019-2030
6.6.3 Argentina Hip Tendinitis Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hip Tendinitis Revenue, 2019-2030
6.7.2 Turkey Hip Tendinitis Market Size, 2019-2030
6.7.3 Israel Hip Tendinitis Market Size, 2019-2030
6.7.4 Saudi Arabia Hip Tendinitis Market Size, 2019-2030
6.7.5 UAE Hip Tendinitis Market Size, 2019-2030
7 Hip Tendinitis Companies Profiles
7.1 Almatica Pharma
7.1.1 Almatica Pharma Company Summary
7.1.2 Almatica Pharma Business Overview
7.1.3 Almatica Pharma Hip Tendinitis Major Product Offerings
7.1.4 Almatica Pharma Hip Tendinitis Revenue in Global Market (2019-2024)
7.1.5 Almatica Pharma Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Hip Tendinitis Major Product Offerings
7.2.4 AstraZeneca Hip Tendinitis Revenue in Global Market (2019-2024)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Hip Tendinitis Major Product Offerings
7.3.4 Bayer Hip Tendinitis Revenue in Global Market (2019-2024)
7.3.5 Bayer Key News & Latest Developments
7.4 Boehringer Ingelheim Pharmaceuticals
7.4.1 Boehringer Ingelheim Pharmaceuticals Company Summary
7.4.2 Boehringer Ingelheim Pharmaceuticals Business Overview
7.4.3 Boehringer Ingelheim Pharmaceuticals Hip Tendinitis Major Product Offerings
7.4.4 Boehringer Ingelheim Pharmaceuticals Hip Tendinitis Revenue in Global Market (2019-2024)
7.4.5 Boehringer Ingelheim Pharmaceuticals Key News & Latest Developments
7.5 Merck & Co.
7.5.1 Merck & Co. Company Summary
7.5.2 Merck & Co. Business Overview
7.5.3 Merck & Co. Hip Tendinitis Major Product Offerings
7.5.4 Merck & Co. Hip Tendinitis Revenue in Global Market (2019-2024)
7.5.5 Merck & Co. Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Hip Tendinitis Major Product Offerings
7.6.4 Pfizer Hip Tendinitis Revenue in Global Market (2019-2024)
7.6.5 Pfizer Key News & Latest Developments
7.7 Abbott
7.7.1 Abbott Company Summary
7.7.2 Abbott Business Overview
7.7.3 Abbott Hip Tendinitis Major Product Offerings
7.7.4 Abbott Hip Tendinitis Revenue in Global Market (2019-2024)
7.7.5 Abbott Key News & Latest Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Company Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Hip Tendinitis Major Product Offerings
7.8.4 GlaxoSmithKline Hip Tendinitis Revenue in Global Market (2019-2024)
7.8.5 GlaxoSmithKline Key News & Latest Developments
7.9 Teva Pharmaceuticals
7.9.1 Teva Pharmaceuticals Company Summary
7.9.2 Teva Pharmaceuticals Business Overview
7.9.3 Teva Pharmaceuticals Hip Tendinitis Major Product Offerings
7.9.4 Teva Pharmaceuticals Hip Tendinitis Revenue in Global Market (2019-2024)
7.9.5 Teva Pharmaceuticals Key News & Latest Developments
7.10 Lupin Pharmaceuticals
7.10.1 Lupin Pharmaceuticals Company Summary
7.10.2 Lupin Pharmaceuticals Business Overview
7.10.3 Lupin Pharmaceuticals Hip Tendinitis Major Product Offerings
7.10.4 Lupin Pharmaceuticals Hip Tendinitis Revenue in Global Market (2019-2024)
7.10.5 Lupin Pharmaceuticals Key News & Latest Developments
7.11 Geri-Care Pharmaceuticals
7.11.1 Geri-Care Pharmaceuticals Company Summary
7.11.2 Geri-Care Pharmaceuticals Business Overview
7.11.3 Geri-Care Pharmaceuticals Hip Tendinitis Major Product Offerings
7.11.4 Geri-Care Pharmaceuticals Hip Tendinitis Revenue in Global Market (2019-2024)
7.11.5 Geri-Care Pharmaceuticals Key News & Latest Developments
7.12 Perrigo Company
7.12.1 Perrigo Company Company Summary
7.12.2 Perrigo Company Business Overview
7.12.3 Perrigo Company Hip Tendinitis Major Product Offerings
7.12.4 Perrigo Company Hip Tendinitis Revenue in Global Market (2019-2024)
7.12.5 Perrigo Company Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hip Tendinitis Market Opportunities & Trends in Global Market
Table 2. Hip Tendinitis Market Drivers in Global Market
Table 3. Hip Tendinitis Market Restraints in Global Market
Table 4. Key Players of Hip Tendinitis in Global Market
Table 5. Top Hip Tendinitis Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Hip Tendinitis Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Hip Tendinitis Revenue Share by Companies, 2019-2024
Table 8. Global Companies Hip Tendinitis Product Type
Table 9. List of Global Tier 1 Hip Tendinitis Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hip Tendinitis Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Hip Tendinitis Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Hip Tendinitis Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Hip Tendinitis Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Hip Tendinitis Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Hip Tendinitis Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Hip Tendinitis Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Hip Tendinitis Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Hip Tendinitis Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Hip Tendinitis Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Hip Tendinitis Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Hip Tendinitis Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Hip Tendinitis Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Hip Tendinitis Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Hip Tendinitis Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Hip Tendinitis Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Hip Tendinitis Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Hip Tendinitis Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Hip Tendinitis Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Hip Tendinitis Revenue, (US$, Mn), 2025-2030
Table 30. Almatica Pharma Company Summary
Table 31. Almatica Pharma Hip Tendinitis Product Offerings
Table 32. Almatica Pharma Hip Tendinitis Revenue (US$, Mn) & (2019-2024)
Table 33. Almatica Pharma Key News & Latest Developments
Table 34. AstraZeneca Company Summary
Table 35. AstraZeneca Hip Tendinitis Product Offerings
Table 36. AstraZeneca Hip Tendinitis Revenue (US$, Mn) & (2019-2024)
Table 37. AstraZeneca Key News & Latest Developments
Table 38. Bayer Company Summary
Table 39. Bayer Hip Tendinitis Product Offerings
Table 40. Bayer Hip Tendinitis Revenue (US$, Mn) & (2019-2024)
Table 41. Bayer Key News & Latest Developments
Table 42. Boehringer Ingelheim Pharmaceuticals Company Summary
Table 43. Boehringer Ingelheim Pharmaceuticals Hip Tendinitis Product Offerings
Table 44. Boehringer Ingelheim Pharmaceuticals Hip Tendinitis Revenue (US$, Mn) & (2019-2024)
Table 45. Boehringer Ingelheim Pharmaceuticals Key News & Latest Developments
Table 46. Merck & Co. Company Summary
Table 47. Merck & Co. Hip Tendinitis Product Offerings
Table 48. Merck & Co. Hip Tendinitis Revenue (US$, Mn) & (2019-2024)
Table 49. Merck & Co. Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Hip Tendinitis Product Offerings
Table 52. Pfizer Hip Tendinitis Revenue (US$, Mn) & (2019-2024)
Table 53. Pfizer Key News & Latest Developments
Table 54. Abbott Company Summary
Table 55. Abbott Hip Tendinitis Product Offerings
Table 56. Abbott Hip Tendinitis Revenue (US$, Mn) & (2019-2024)
Table 57. Abbott Key News & Latest Developments
Table 58. GlaxoSmithKline Company Summary
Table 59. GlaxoSmithKline Hip Tendinitis Product Offerings
Table 60. GlaxoSmithKline Hip Tendinitis Revenue (US$, Mn) & (2019-2024)
Table 61. GlaxoSmithKline Key News & Latest Developments
Table 62. Teva Pharmaceuticals Company Summary
Table 63. Teva Pharmaceuticals Hip Tendinitis Product Offerings
Table 64. Teva Pharmaceuticals Hip Tendinitis Revenue (US$, Mn) & (2019-2024)
Table 65. Teva Pharmaceuticals Key News & Latest Developments
Table 66. Lupin Pharmaceuticals Company Summary
Table 67. Lupin Pharmaceuticals Hip Tendinitis Product Offerings
Table 68. Lupin Pharmaceuticals Hip Tendinitis Revenue (US$, Mn) & (2019-2024)
Table 69. Lupin Pharmaceuticals Key News & Latest Developments
Table 70. Geri-Care Pharmaceuticals Company Summary
Table 71. Geri-Care Pharmaceuticals Hip Tendinitis Product Offerings
Table 72. Geri-Care Pharmaceuticals Hip Tendinitis Revenue (US$, Mn) & (2019-2024)
Table 73. Geri-Care Pharmaceuticals Key News & Latest Developments
Table 74. Perrigo Company Company Summary
Table 75. Perrigo Company Hip Tendinitis Product Offerings
Table 76. Perrigo Company Hip Tendinitis Revenue (US$, Mn) & (2019-2024)
Table 77. Perrigo Company Key News & Latest Developments
List of Figures
Figure 1. Hip Tendinitis Segment by Type in 2023
Figure 2. Hip Tendinitis Segment by Application in 2023
Figure 3. Global Hip Tendinitis Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Hip Tendinitis Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Hip Tendinitis Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hip Tendinitis Revenue in 2023
Figure 8. By Type - Global Hip Tendinitis Revenue Market Share, 2019-2030
Figure 9. By Application - Global Hip Tendinitis Revenue Market Share, 2019-2030
Figure 10. By Type - Global Hip Tendinitis Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Hip Tendinitis Revenue Market Share, 2019-2030
Figure 12. By Application - Global Hip Tendinitis Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Hip Tendinitis Revenue Market Share, 2019-2030
Figure 14. By Region - Global Hip Tendinitis Revenue Market Share, 2019-2030
Figure 15. By Country - North America Hip Tendinitis Revenue Market Share, 2019-2030
Figure 16. US Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Hip Tendinitis Revenue Market Share, 2019-2030
Figure 20. Germany Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 21. France Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Hip Tendinitis Revenue Market Share, 2019-2030
Figure 28. China Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 32. India Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Hip Tendinitis Revenue Market Share, 2019-2030
Figure 34. Brazil Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Hip Tendinitis Revenue Market Share, 2019-2030
Figure 37. Turkey Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Hip Tendinitis Revenue, (US$, Mn), 2019-2030
Figure 41. Almatica Pharma Hip Tendinitis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. AstraZeneca Hip Tendinitis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Bayer Hip Tendinitis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Boehringer Ingelheim Pharmaceuticals Hip Tendinitis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Merck & Co. Hip Tendinitis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Pfizer Hip Tendinitis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Abbott Hip Tendinitis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. GlaxoSmithKline Hip Tendinitis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Teva Pharmaceuticals Hip Tendinitis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Lupin Pharmaceuticals Hip Tendinitis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Geri-Care Pharmaceuticals Hip Tendinitis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Perrigo Company Hip Tendinitis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
